Print E-mail Contact us
News & Events
HD Biosciences Merges with WuXi AppTec
HD Biosciences and Luxcel Biosciences Enter Collaboration Agreement for Mitochondria Toxicity & Metabolism Assays for Preclinical Drug Safety Evaluation
HD Biosciences Hosted Opening Ceremony for New Operation Facility in Zhang Jiang Hi-Tech Park in Shanghai
HD Biosciences Received Numerous "Vendor Appreciation and Special Contribution" Awards from Its Partners and Clients for the Impacts to Their Drug Discovery Portfolio Development
HD Biosciences and ABBIOSCI Formed Partnership on Antibody Drug Discovery Services
HD Biosciences Announces New Operation Facility in San Diego, CA, USA
HD Biosciences Co., Ltd. to Exhibit at SLAS2015 in Washington DC, USA
HD Biosciences Co., Ltd. successfully exhibited at MipTec in Basel, Switzerland
HD Biosciences and Marshall University Reach Drug Discovery Co-development Agreement
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery
HD Biosciences to Exhibit at MipTec in Basel, Switzerland
HD Biosciences Successfully Hosted its First Partners Group Meeting in Shanghai
HD Biosciences, Corp. to Host Its First Partners Group Meeting (PGM) in Shanghai
HD Biosciences Appoints Dr. Yongjie Zhuang (Eiketsu Sho) as Executive Director of in vivo Pharmacology
HD Biosciences Appoints Dr. John Shen as Vice President of Corporate Relationship
HD Biosciences Exhibited at SLAS 2014 in San Diego, California
HD Biosciences Exhibits at SLAS 2014 in San Diego, California
HD Biosciences Listed Again on "2013 Deloitte Technology Fast 500 Asia Pacific"
HD Biosciences and Anchor Therapeutics Form Collaboration for Co-marketing Pepducin-mediated GPCR Technology
HDB Signed a Multiple FTE Agreement with a Global Leading Pharmaceutical Company
HD Biosciences Achieved 5 Million Data Points in 2012 from High throughput and SAR Screening Services
HD Biosciences Makes Remarkable Progress in Viral Vector Mediated Gene Manipulation Platform for Target Discovery Services
HD Biosciences Announces the Opening of a New Facility in Zhangjiang High Tech Park
HD Biosciences Made Remarkable Achievement in Plate Based Pharmacology Services
HD Biosciences Ranks in “2011 Deloitte Technology Fast 50 China”
HD Biosciences Announces the Appointment of Dr. Maosheng Duan as Vice President and Head of Medicinal Chemistry.
HD Biosciences Launches Medicinal Chemistry for SAR Focused R&D Services.
HD Biosciences Co. LTD Received AAALAC Accreditation on Its Animal Facility.
Histone deacetylase inhibitor screening platform established at HDB.
HDB gains international recognition for its in vivo pharmacology in behavioral research area.
HDB animal facility has received approval from an unnamed global pharmaceutical company for its in vivo research.
A high throughput CYP450 cocktail IC50 assay has been developed recently by the DMPK and Analytical team of HDB.
HD Biosciences partners with Discoverx Corp. to Provide Services With Innovative Technology Platforms.
Pfizer awarded HDB’s scientific leader "Different Marker" for her great contribution in one of the research collaborations.
HDB granted “fast track custom clearance” green channel privilege in Zhang Jiang Shanghai.
CellCentric Expands Drug Screening Collaborations with HDB in Shanghai.
HDB Announces the Appointment of Several Positions in DMPK. Bioanalytical Service and in vitro Toxicology.
HD Biosciences Moved to the Zhangjiang East Campus.
HD Biosciences Co., Ltd. (HDB) was awarded “2008 Top Research Service Partner Award” by Pfizer Inc in recognition of quality, productivity, and value that HD Biosciences brought to Pfizer over the past year.
HD Biosciences Adds New Tools to Enhance Assay and Screening Facilities.
HD Biosciences successfully launched Wash Free Fluo-8 Calcium Assay Kits to the market. Good news for researchers around the world that Wash free Fluo-8 Calcium Assay kit with much higher signal intensity and assay robustness is now available.
Oct. 2, 2008 - HD Biosciences Announces a grand renovation plan to its newly leased facility in Zhangjiang Hi-Tech Park (East).
HD Biosciences Announces the Appointment of Senior Vice President of Discovery Biology. Sept. 8, 2008 - HD Biosciences Inc. (HDB) announces the hiring of Dr. Peiyuan Lin as Senior Vice President of Discovery Biology.
HD Biosciences Announces the Appointment of Head of Business Development and Project Development. Sept. 8, 2008 - HD Biosciences Inc. (HDB) announces the hiring of Dr. Angela Chen as Head of Business Development and Project Management.
HD Biosciences Announces Completion of Series A Financing. The current round was co-led by Morningside Venture, a private investment group founded by Hong Kong's Chan family, and Lilly Asian Ventures, the Asian venture arm of Eli Lilly & Co. And Pfizer Venture Investments, the venture arm of Pfizer Inc, also participated in this round.
HD Biosciences Announces the Appointment of VP of HTS Screening. July 7, 2008 -- HD Biosciences Inc. (HDB) announces the hiring of Dr. Shaoming Huang as Vice President, High Throughput Screening (HTS).
HD Biosciences, Sundia, and European Company NovaSecta Join CRO Service Alliance for Drug Discovery Solutions.
----------------------
----------------------
HD Biosciences (China) Co.,Ltd
590 Ruiqing Road
Zhangjiang East Campus, Pudong, Shanghai 201201,
P.R.China
Tel: +86 (21) 5116 3700
Fax: +86 (21) 5116 3766
info@hdbiosciences.com
SERVICES
|
THERAPEUTIC AREAS
|
NEWS & EVENTS